Biopsies from patients diagnosed with CTCL demonstrated a stage-dependent increase in the mean microvessel density and malignant CTCL T cells have been shown to express several angiogenic factors, including VEGF [20]. This evidence concerns the gene VEGFA and primary cutaneous T-cell non-Hodgkin lymphoma.